Mohamad NASSER

Mohamad NASSER


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2023 in Life
Verified
Journal Article
Open access
PDF file
GAGhosoon Emad Albahri
Ghosoon Emad Albahri
ABAdnan Badran
Adnan Badran
AHAkram Hijazi
Akram Hijazi
Anis DaouAnis Daou
Anis Daou
EBElias Baydoun
Elias Baydoun
Othmane MerahOthmane Merah
Othmane Merah
The skin serves as the body’s first line of defense, guarding against mechanical, chemical, and thermal damage to the interior organs. It includes a highly developed immune response that serves as a barrier against pathogenic infections. Wound healing is a dynamic process underpinned by numerous cellular activities, including homeostasis, inflammation, proliferation, and remodeling, that require proper harmonious integration to effectively repair the damaged tissue. Following cutaneous damage, microorganisms can quickly enter the tissues beneath the skin, which can result in chronic wounds and fatal infections. Natural phytomedicines that possess considerable pharmacological properties have been widely and effectively employed forwound treatment and infection prevention. Since ancient times, phytotherapy has been able to efficiently treat cutaneous wounds, reduce the onset of infections, and minimize the usage of antibiotics that cause critical antibiotic resistance. There are a remarkable number of wound-healing botanicals that have been widely used in the Northern Hemisphere, including Achiella millefolium, Aloe vera, Althaea officinalis, Calendula officinalis, Matricaria chamomilla, Curcuma longa, Eucalyptus, Jojoba, plantain, pine, green tea, pomegranate, and Inula. This review addresses the most often used medicinal plants from the Northern Hemisphere that facilitate the treatment of wounds, and also suggests viable natural alternatives that can be used in the field of wound care.

26 June 2023 in Agronomy
Verified
Journal Article
Open access
PDF file
GAGhosoon Emad Albahri
Ghosoon Emad Albahri
AAAmal A. Alyamani
Amal A. Alyamani
ABAdnan Badran
Adnan Badran
AHAkram Hijazi
Akram Hijazi
MNMohamad NASSER
Mohamad NASSER
EBElias Baydoun
Elias Baydoun
A key concern in agriculture is how to feed the expanding population and safeguard the environment from the ill effects of climate change. To feed a growing global population, food production and security are significant problems, as food output may need to double by 2050. Thus, more innovative and effective approaches for increasing agricultural productivity (hence, food production) are required to meet the rising demand for food. The world’s most widely cultivated grains include corn, wheat, and rice, which serve as the foundation for basic foods. This review focuses on some of the key most up-to-date approaches that boost wheat, rice, corn, barley, and oat yields with insight into how molecular technology and genetics may raise the production and resource-efficient use of these important grains. Although red light management and genetic manipulation show maximal grain yield enhancement, other covered strategies including bacterial-nutrient management, solar brightening, facing abiotic stress through innovative agricultural systems, fertilizer management, harmful gas emissions reduction, photosynthesis enhancement, stress tolerance, disease resistance, and varietal improvement also enhance grain production and increase plant resistance to harmful environmental circumstances. This study also discusses the potential challenges of the addressed approaches and possible future perspectives.

18 February 2015 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
ADAurore Danigo
Aurore Danigo
MNMohamad NASSER
Mohamad NASSER
FBFlavien Bessaguet
Flavien Bessaguet
JJJames Javellaud
James Javellaud
NONicole Oudart
Nicole Oudart
Claire DemiotClaire Demiot
Claire Demiot
Angiotensin II type 1 receptor (AT1R) blockers have beneficial effects on neurovascular complications in diabetes and in organ’s protection against ischemic episodes. The present study examines whether the AT1R blocker candesartan (1) has a beneficial effect on diabetes-induced alteration of pressure-induced vasodilation (PIV, a cutaneous physiological neurovascular mechanism which could delay the occurrence of tissue ischemia), and (2) could be protective against skin pressure ulcer formation. Male Swiss mice aged 5–6 weeks were randomly assigned to four experimental groups. In two groups, diabetes was induced by a single intraperitoneal injection of streptozotocin (STZ, 200 mg.kg−1). After 6 weeks, control and STZ mice received either no treatment or candesartan (1 mg/kg-daily in drinking water) during 2 weeks. At the end of treatment (8 weeks of diabetes duration), C-fiber mediated nociception threshold, endothelium-dependent vasodilation and PIV were assessed. Pressure ulcers (PUs) were then induced by pinching the dorsal skin between two magnetic plates for three hours. Skin ulcer area development was assessed during three days, and histological examination of the depth of the skin lesion was performed at day three. After 8 weeks of diabetes, the skin neurovascular functions (C-fiber nociception, endothelium-dependent vasodilation and PIV) were markedly altered in STZ-treated mice, but were fully restored by treatment with candesartan. Whereas in diabetes mice exposure of the skin to pressure induced wide and deep necrotic lesions, treatment with candersartan restored their ability to resist to pressure-induced ulceration as efficiently as the control mice. Candesartan decreases the vulnerability to pressure-induced ulceration and restores skin neurovascular functions in mice with STZ-induced established diabetes.

10 February 2014 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
MNMohamad NASSER
Mohamad NASSER
NCNicolas Clere
Nicolas Clere
LBLaurent Botelle
Laurent Botelle
JJJames Javellaud
James Javellaud
NONicole Oudart
Nicole Oudart
JAJean-Michel Achard
Jean-Michel Achard
We examined the effect of chronic administration of angiotensin IV (AngIV) on the vascular alterations induced by type 1 diabetes in mice.

15 October 2020 in Medicines
Verified
Journal Article
Open access
PDF file
MNMohamad NASSER
Mohamad NASSER
ZDZiad Damaj
Ziad Damaj
AHAkram Hijazi
Akram Hijazi
Othmane MerahOthmane Merah
Othmane Merah
BABatoul Al-khatib
Batoul Al-khatib
MNMouhamad Nasser
Mouhamad Nasser
Background: Lung cancer is one of the most prevalent cancers worldwide. Chemotherapy regimens, targeted against lung cancer, are considered an effective treatment; albeit with multiple fatal side effects. An alternative strategy, nowadays, is using natural products. Medicinal plants have been used, in combination with chemotherapy, to ameliorate side effects. This study aims to investigate the antitumor effect of pomegranate juice (Punica granatum) on human lung adenocarcinoma basal epithelial cells (A549), to check the effect, when combined with low dose cisplatin (CDDP), at different doses. We also have evaluated the potential protective effect of pomegranate on normal peripheral blood mononuclear cells (PBMC). Methods: Phytochemical screening of the extract was done using standard classical tests. Total phenolic and sugar contents were determined using the Folin–Ciocalteu and anthrone reagents, respectively. The antioxidant activity of pomegranate was estimated by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method. The viability of A549 cells and PBMC was evaluated using the neutral red assay. Results: Our results demonstrated that Punica granatum or pomegranate juice (with different concentrations: 150, 300, 600 µg/mL) contained high levels of flavonoids, alkaloids, tanins, lignins, terpenoids, and phenols. The DPPH method showed that pomegranate juice had a strong antioxidant scavenging activity. Neutral red showed that combining pomegranate juice with low dose CDDP (8 µg/mL) decreased the cell viability of A549 cells, by 64%, compared to treatment with CDDP or pomegranate alone. When added to low dose CDDP, pomegranate increased the viability of normal PBMC cells by 46%. Conclusions: These results demonstrated that pomegranate could potentiate the anticancer effect of low dose CDDP on human lung adenocarcinoma cells (A549 cells) and could as well decrease its toxicity on PBMC.

14 November 2019 in Revue Vétérinaire Clinique
Verified
Journal Article
Closed access
FSF. Stephan
F. Stephan
DSD. Saade
D. Saade
MNMohamad NASSER
Mohamad NASSER